Cargando…
Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
The treatments available for thalassemia are rapidly evolving, with major advances made in gene therapy and the modulation of erythropoiesis. The latter includes the therapeutic potential of hepcidin tuning. In thalassemia, hepcidin is significantly depressed, and any rise in hepcidin function has a...
Autores principales: | Longo, Filomena, Piga, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457499/ https://www.ncbi.nlm.nih.gov/pubmed/36079046 http://dx.doi.org/10.3390/jcm11175119 |
Ejemplares similares
-
The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients
por: Barbero, Umberto, et al.
Publicado: (2021) -
Exercise Stress Echocardiography with Tissue Doppler Imaging (TDI) Detects Early Systolic Dysfunction in Beta-Thalassemia Major Patients without Cardiac Iron Overload
por: Barbero, Umberto, et al.
Publicado: (2012) -
The Relation between Serum Hepcidin, Ferritin, Hepcidin: Ferritin Ratio, Hydroxyurea and Splenectomy in Children with β-Thalassemia
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2019) -
Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
por: Fekri, Kiavash, et al.
Publicado: (2019) -
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
por: Piga, Antonio, et al.
Publicado: (2022)